Immune Surveillance of Tumors.
From: Cancer Immunology Program, Peter MacCallum Cancer Centre, East Melbourne 8006, Victoria, Australia.
The Journal of clinical investigation
- Publish Date: May 2007
- ISSN: 0021-9738
- Volume: 117
- Issue: 5
- Pages: 1137-46
- Medium: Print
- Language: English
- Citation (JAMA): Swann Jeremy B, Smyth Mark J, et al. Immune Surveillance of Tumors.. J. Clin. Invest. May 2007;117:1137-46
Abstract
The ability of the immune system to identify and destroy nascent tumors, and to thereby function as a primary defense against cancer, has been debated for many decades. Recent findings by a number of investigators in both mouse models of cancer and humans with cancer now offer compelling evidence that particular immune cell types, effector molecules, and pathways can sometimes collectively function as extrinsic tumor suppressor mechanisms. This work provides the basis for further study of natural immunity to cancer and for rational use of this information in the design of immunotherapies in combination with other conventional cancer treatments.
Mesh Headings (Keywords): Animals, Humans, Immunologic Surveillance, Neoplasms
Check for Full Text / PubMed Unique Identifier (PMID): 17476343
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.